Saxenda Side Effects (2026): What's Common, What's Serious & How to Manage Them

The most common Saxenda side effects are gastrointestinal and usually mild-to-moderate: nausea, diarrhea, constipation, vomiting, and decreased appetite, driven by how the drug slows the gut and curbs appetite. In the Saxenda obesity trials, nausea was the single most frequent reaction — reported by roughly 39% of patients — and was heaviest in the first weeks and right after each weekly dose increase, easing as the body adapts.^[1][2] Saxenda is also a once-daily injection, so unlike weekly GLP-1 drugs the exposure is steady each day rather than peaking once a week. A smaller number of effects are serious and warrant prompt medical attention — pancreatitis, gallbladder disease, acute kidney injury from dehydration, low blood sugar (especially with insulin or a sulfonylurea in type 2 diabetes), increased heart rate, hypersensitivity reactions, and the label's directive to monitor for depression or suicidal thoughts — and Saxenda carries an FDA boxed warning for the risk of thyroid C-cell tumors based on rodent studies.^[1] This guide separates what is common and expected from what is rare and serious, explains why the GI effects happen, and lays out exactly when to call your prescriber. Saxenda is liraglutide 3 mg (Novo Nordisk); see the Saxenda dosage chart for the weekly titration that drives much of the tolerability picture, and browse GLP-1 medications for how it compares. This is general educational information, not medical advice — your prescriber manages your care.

The most common side effects

By a wide margin, the most common Saxenda side effects are gastrointestinal. In the placebo-controlled clinical trials summarized in the FDA label §6, the reactions reported most often were nausea, diarrhea, constipation, vomiting, decreased appetite, dyspepsia (indigestion), and abdominal pain, alongside headache, fatigue, dizziness, and injection-site reactions.^[1] These are typically mild to moderate, are most pronounced in the first weeks and right after each weekly dose increase, and tend to ease over time as the body adapts.

• Nausea — the most common reaction, reported by roughly 39% of patients in the obesity trials versus about 14% on placebo. Usually transient and most intense during weekly dose escalation.^[1][2]
• Diarrhea — common, on the order of ~21% of patients versus about 10% on placebo.^[1]
• Constipation — roughly ~19% of patients; the flip side of the same gut-slowing mechanism that can cause diarrhea in others.^[1]
• Vomiting — reported by roughly ~16% of patients, clustering around dose escalations.^[1]
• Decreased appetite — roughly ~10%; for a weight-management medication this is partly the intended effect rather than a true adverse event.^[1]
• Hypoglycemia (in type 2 diabetes) — low blood sugar is among the most common reactions specifically in patients who also have type 2 diabetes, particularly when Saxenda is combined with insulin or a sulfonylurea.^[1]
• Headache, fatigue, and dizziness — reported more often than with placebo, frequently overlapping with the GI symptoms and reduced food intake.^[1]
• Injection-site reactions — redness, irritation, or a small lump at the daily injection spot; usually mild. Rotating sites helps.^[1]

Other reactions seen more often than with placebo include dyspepsia (indigestion), abdominal pain, upper abdominal pain, gastroenteritis, eructation (burping), flatulence, and dry mouth, along with increased lipase on bloodwork.^[1] The table and chart below put the headline GI rates side by side against placebo so you can see how much of each is drug-attributable.

Why they happen — the daily-injection and titration angle

Liraglutide is a GLP-1 receptor agonist, and the gastrointestinal side effects are a direct consequence of how it works rather than a quirk to be surprised by. GLP-1 receptor activation slows gastric emptying (food leaves the stomach more slowly), acts on appetite and satiety signaling in the brain, and influences gut motility. Slowed gastric emptying and altered motility are exactly what produce nausea, fullness, vomiting, and the constipation-or-diarrhea swing. Because these effects scale with dose, they are most intense when the dose goes up.^[1]

Saxenda differs from weekly GLP-1 medications in a way that matters for side effects: it is a once-daily injection, and it is titrated on a weekly schedule. The label starts every patient at 0.6 mg once daily for one week, then steps the dose up by 0.6 mg each week — to 1.2 mg, 1.8 mg, 2.4 mg, and finally the maintenance dose of 3 mg once daily — holding one week at each rung.^[1] The low starting dose is explicitly non-therapeutic for weight loss; it exists only to improve gastrointestinal tolerability. The daily rhythm means exposure is steady each day rather than spiking once a week, so for some people nausea is a lower-grade, more constant background sensation that climbs at each weekly step-up. The practical takeaway: rushing the schedule predictably worsens GI side effects, and the label allows delaying a dose increase by up to about a week if a step is not tolerated. The full schedule is laid out in our Saxenda dosage chart, and you can preview the typical symptom arc with the GLP-1 side-effect timeline.

Serious but less common side effects

Beyond the common GI reactions, the Saxenda label §5 lists several serious but less common risks. These are uncommon, but each warrants awareness because some require stopping the drug and seeking care. None of this is a reason to fear the medication — it is the reason Saxenda is a prescription drug taken under medical supervision rather than something you self-manage.

• Pancreatitis (inflammation of the pancreas). Acute pancreatitis has been reported. If pancreatitis is suspected, Saxenda should be discontinued. Warning signs: severe, persistent abdominal pain that may radiate to the back, sometimes with vomiting.^[1]
• Gallbladder disease (cholelithiasis). Gallstones and acute gallbladder inflammation occurred more often with Saxenda than placebo, partly linked to substantial or rapid weight loss. Symptoms include upper-right abdominal pain, fever, jaundice (yellowing of skin or eyes), and clay-colored stools.^[1]
• Acute kidney injury (AKI). Reported, mostly in the setting of nausea, vomiting, and diarrhea leading to dehydration and reduced kidney perfusion; it can worsen pre-existing kidney disease. Staying hydrated during GI side effects matters.^[1]
• Hypoglycemia (low blood sugar). In patients with type 2 diabetes, the risk of low blood sugar rises substantially when Saxenda is combined with insulin or an insulin secretagogue such as a sulfonylurea; the dose of the secretagogue or insulin may need to be lowered. Saxenda is not indicated to treat diabetes.^[1]
• Increased heart rate. Saxenda raises resting heart rate by an average of about 2-3 beats per minute, and some patients have larger increases. Prescribers monitor heart rate, and the label advises discontinuing if a sustained increase is observed.^[1]
• Suicidal behavior and ideation. The label directs prescribers to monitor patients for depression or suicidal thoughts; patients with such symptoms should be evaluated, and Saxenda discontinued if they arise. Anyone with a history of suicidal ideation should be watched closely.^[1]
• Serious allergic reactions (hypersensitivity). Anaphylaxis and angioedema have been reported with liraglutide. Stop Saxenda and seek care for swelling of the face/lips/tongue/throat, difficulty breathing, or a severe rash.^[1]

The boxed warning: thyroid C-cell tumors

Saxenda's single most serious warning is its FDA boxed warning (the strongest warning the FDA issues) for the risk of thyroid C-cell tumors. In two-year studies in rats and mice, liraglutide caused dose-dependent and treatment-duration-dependent thyroid C-cell tumors, including medullary thyroid carcinoma, at clinically relevant exposures.^[1]

The critical nuances: this finding is from rodent studies, and it is not known whether Saxenda causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans — the human relevance of the rodent signal has not been determined. Because of it, Saxenda is contraindicated in patients with a personal or family history of MTC and in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).^[1] Patients should be counseled on the symptoms of thyroid tumors — a lump or mass in the neck, hoarseness, trouble swallowing, or shortness of breath. This is why a legitimate prescriber screens your personal and family thyroid history before starting Saxenda; a source that skips that screening is a safety red flag.

How to manage the common side effects

The GI side effects are usually manageable, and most strategies are about working with the slow-titration design rather than against it. The following are general, commonly-discussed approaches — all of them are prescriber-directed, and you should not change your dose, add medications, or stop Saxenda without talking to your clinician.

• Respect the weekly titration schedule. Most nausea spikes right after a dose increase and settles within days. If a rung is rough, your prescriber can keep you on the current dose longer before stepping up — the label allows delaying an increase by about a week, and slower is safer than pushing through.^[1]
• Eat smaller, slower, lower-fat meals. Because the stomach empties more slowly on liraglutide, large or greasy meals tend to worsen nausea and fullness. Smaller portions, eating slowly, and stopping at "satisfied" rather than "full" usually help.
• Stay hydrated — especially if you have vomiting or diarrhea. This is not just comfort: dehydration from GI symptoms is the main pathway to the acute kidney injury risk above, so keeping fluids up is a genuine safety measure.^[1]
• Manage constipation actively. Adequate fluids, dietary fiber, and movement help; your prescriber may suggest an over-the-counter option. Persistent severe constipation with abdominal distension should be reported, not just self-treated.
• Rotate your injection sites. Because Saxenda is injected daily, rotating among the abdomen, thigh, and upper arm reduces injection-site irritation and lumps. Never share a pen, even with a new needle.^[1]
• Watch interacting medications and your mood. If you also take insulin or a sulfonylurea for type 2 diabetes, your prescriber may lower those doses to reduce hypoglycemia risk; don't adjust them on your own. And because the label directs monitoring for depression or suicidal thoughts, tell your prescriber promptly about any new or worsening mood changes.^[1]

To map your dose-escalation dates against the typical symptom arc, use the GLP-1 side-effect timeline. For how Saxenda's daily liraglutide compares with the once-weekly semaglutide drugs, see our guide to Ozempic side effects.

When to call your provider — or stop and seek urgent care

Most Saxenda side effects are mild and self-limiting, but a defined set of symptoms means contact your prescriber promptly, and some mean stop and seek urgent/emergency care. Use this as a general guide, not a substitute for your clinician's instructions, and when in doubt, call.

• Seek emergency care for signs of a serious allergic reaction: swelling of the face, lips, tongue, or throat, trouble breathing, or a severe spreading rash.^[1]
• Seek urgent care for severe, persistent abdominal pain (especially radiating to the back, with or without vomiting) — a possible sign of pancreatitis — and stop Saxenda until evaluated.^[1]
• Call your prescriber promptly for upper-right abdominal pain, fever, or yellowing of the skin/eyes — possible gallbladder disease.^[1]
• Call your prescriber if vomiting or diarrhea is severe enough that you can't keep fluids down, to head off dehydration and kidney injury — and, if you have type 2 diabetes, treat low-blood-sugar symptoms (shakiness, sweating, confusion, fast heartbeat) per your clinician's plan, especially if you also use insulin or a sulfonylurea.^[1]
• Contact your prescriber about a persistently fast or pounding heartbeat, or any new or worsening depression, mood changes, or thoughts of self-harm — both are explicitly monitored on the Saxenda label.^[1]
• Report any neck lump or mass, hoarseness, trouble swallowing, or shortness of breath — the thyroid-tumor symptoms tied to the boxed warning.^[1]

If you are evaluating where to start or continue treatment under proper medical supervision, compare the best GLP-1 providers, or read our reviews of Found and Ro. A legitimate provider screens you for the contraindications above, titrates you on the label schedule, monitors heart rate and mood, and follows up on side effects — exactly the monitoring that keeps Saxenda's risk profile manageable.